Dolby Laboratories Future Growth

NYSE:DLB - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
9/30/2026	1,443	301	N/A	N/A	1
9/30/2025	1,334	265	N/A	N/A	3
9/30/2024	1,277	241	280	N/A	3
6/28/2024	1,259	212	265	296	N/A
3/29/2024	1,269	190	365	396	N/A
12/29/2023	1,280	188	290	319	N/A
9/29/2023	1,300	201	337	367	N/A
6/30/2023	1,287	219	301	333	N/A
3/31/2023	1,279	242	348	385	N/A
12/30/2022	1,237	183	303	343	N/A
9/30/2022	1,254	184	259	319	N/A
7/1/2022	1,261	201	316	377	N/A
4/1/2022	1,258	216	314	377	N/A
12/31/2021	1,243	255	332	397	N/A
9/24/2021	1,281	310	393	448	N/A
6/25/2021	1,267	293	398	451	N/A
3/26/2021	1,228	306	359	413	N/A
12/25/2020	1,260	318	334	395	N/A
9/25/2020	1,162	231	275	344	N/A
6/26/2020	1,189	248	287	362	N/A
3/27/2020	1,245	221	234	319	N/A
12/27/2019	1,231	206	195	302	N/A
9/27/2019	1,242	255	214	328	N/A
6/28/2019	1,183	238	194	309	N/A
3/29/2019	1,096	201	253	360	N/A
12/28/2018	1,057	193	307	392	N/A
9/28/2018	1,055	42	267	352	N/A
6/29/2018	1,056	37	236	321	N/A
3/30/2018	1,147	110	N/A	317	N/A
12/29/2017	1,115	95	N/A	324	N/A
9/29/2017	1,080	206	N/A	378	N/A
6/30/2017	1,072	204	N/A	370	N/A
3/31/2017	1,044	192	N/A	359	N/A
12/30/2016	1,051	208	N/A	360	N/A
9/30/2016	1,026	186	N/A	360	N/A
7/1/2016	1,025	208	N/A	367	N/A
4/1/2016	980	180	N/A	288	N/A
1/1/2016	977	171	N/A	373	N/A
9/25/2015	971	181	N/A	309	N/A
6/26/2015	965	181	N/A	316	N/A
3/27/2015	956	185	N/A	360	N/A
12/26/2014	963	203	N/A	288	N/A
9/26/2014	960	206	N/A	362	N/A
6/27/2014	950	206	N/A	339	N/A
3/28/2014	934	196	N/A	332	N/A
12/27/2013	904	182	N/A	286	N/A
9/27/2013	910	189	N/A	277	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DLB's forecast earnings growth (14% per year) is above the savings rate (2.5%).

Earnings vs Market: DLB's earnings (14% per year) are forecast to grow slower than the US market (15% per year).

High Growth Earnings: DLB's earnings are forecast to grow, but not significantly.

Revenue vs Market: DLB's revenue (5.5% per year) is forecast to grow slower than the US market (8.7% per year).

High Growth Revenue: DLB's revenue (5.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if DLB's Return on Equity is forecast to be high in 3 years time

Dolby Laboratories Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Price target decreased by 9.1% to US$94.95

Dolby Laboratories, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Dolby Laboratories, Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2024

Price target increased by 8.4% to US$107

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2023

Recent updates

Dolby Laboratories: Need To See Improvements In Sales Before Committing Capital

Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Matching Investor Opinion

Third quarter dividend of US$0.30 announced

Third quarter 2024 earnings: EPS exceeds analyst expectations

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on August 27, 2024

Now 20% undervalued after recent price drop

Dolby Laboratories, Inc. (NYSE:DLB) acquired THEOplayer.

We Like These Underlying Return On Capital Trends At Dolby Laboratories (NYSE:DLB)

Dolby Laboratories, Inc. to Report Q3, 2024 Results on Aug 07, 2024

Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation

Dolby Laboratories, Inc. (NYSE:DLB) entered into a definitive agreement to acquire Ge Trademark Licensing, Inc. from General Electric Company (NYSE:GE) for approximately $430 million.

Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?

Dolby Laboratories Remains A Hold

Second quarter dividend of US$0.30 announced

Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on May 22, 2024

Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors

Price target decreased by 9.1% to US$94.95

Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist

Dolby Laboratories, Inc. to Report Q2, 2024 Results on May 02, 2024

Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate

Senior VP & Chief Marketing Officer recently sold US$1.0m worth of stock

Insufficient new directors

Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)

Senior Vice President of Entertainment notifies of intention to sell stock

Dolby Laboratories, Inc. Announces Committee Changes

Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye

First quarter dividend of US$0.30 announced

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Dolby Laboratories, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Now 20% undervalued

President notifies of intention to sell stock

With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For

Dolby Laboratories, Inc. to Report Q1, 2024 Results on Feb 01, 2024

The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising

Dolby Laboratories, Inc., Annual General Meeting, Feb 06, 2024

President notifies of intention to sell stock

Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue

President notifies of intention to sell stock

Full year 2023 earnings: EPS misses analyst expectations

A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Dolby Laboratories, Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2024

President notifies of intention to sell stock

At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?

Dolby Laboratories, Inc. to Report Fiscal Year 2023 Results on Nov 16, 2023

President notifies of intention to sell stock

Dolby Laboratories: High P/E Is Not Justified, A Hold For Now

Senior VP & Chief Marketing Officer notifies of intention to sell stock

Dolby Laboratories, Inc. Unveils New Dolby Atmos Innovation Coming to TCL TVS Ahead of IFA 2023

Price target increased by 8.4% to US$107

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2023

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

Dolby Laboratories, Inc. to Report Q3, 2023 Results on Aug 03, 2023

President notifies of intention to sell stock

What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?

Dolby Laboratories Sees Return To Growth Ahead

President notifies of intention to sell stock

President notifies of intention to sell stock

Executive VP notifies of intention to sell stock

Dolby Laboratories, Inc. Announces Cash Dividend, Payable on May 23, 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture

President notifies of intention to sell stock

A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)

Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?

President notifies of intention to sell stock

Independent Director notifies of intention to sell stock